MedPath

海南美兰史克制药有限公司

Ownership
-
Established
2002-01-24
Employees
-
Market Cap
-
Website
www.mlskzy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

52

NMPA:52

Drug Approvals

Vecuronium Bromide for Injection

Product Name
注射用维库溴铵
Approval Number
国药准字H20258055
Approval Date
Apr 7, 2025
NMPA

Levocarnitine Injection

Product Name
左卡尼汀注射液
Approval Number
国药准字H20247206
Approval Date
Sep 10, 2024
NMPA

咳特灵胶囊

Approval Number
国药准字Z46020050
Approval Date
Jul 15, 2024
NMPA

复方感冒灵片

Approval Number
国药准字Z46020049
Approval Date
Jul 10, 2024
NMPA

消炎利胆片

Approval Number
国药准字Z46020051
Approval Date
Jul 10, 2024
NMPA

补肾强身胶囊

Approval Number
国药准字Z46020026
Approval Date
Jul 10, 2024
NMPA

麝香接骨胶囊

Approval Number
国药准字Z46020028
Approval Date
Jul 10, 2024
NMPA

麝香风湿胶囊

Approval Number
国药准字Z46020041
Approval Date
Jul 10, 2024
NMPA

复方穿心莲片

Approval Number
国药准字Z46020043
Approval Date
Jul 10, 2024
NMPA

感冒清片

Approval Number
国药准字Z46020039
Approval Date
Jul 10, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.